Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Gebauer's Sprays After ChloraPrep
NCT04207710Phase 4Completed
- Sponsor
- Henry Ford Health
- Start
- Jan 2021
- Primary completion
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of ethyl chloride and Gebauer's Spray and Stretch in procedural pain (2 arms), sponsored by Henry Ford Health. Primary endpoint: Presence of Microbial Growth (1+ CFU) at 3 days. Started Jan 2021; status: completed.
02
Drugs
ethyl chlorideGebauer's Spray and Stretch
03
Conditions
procedural pain
Beyond the preview
Go deeper on NCT04207710.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04207710.